News
From idea to drug
Published March 03, 2023
One of our non-academic beneficiary AstraZeneca, hosted our PhD students for one whole week at their premesis in Gothenburg, Sweden. As the majority of our students are recruited by academic institutions, this inter-disciplinary experience was even more valuable for the consortium. The objectives of this week was to gain understanding of principles of human target validation and drug target candidate assessment following the 5R framework.
Their training focused on target, tissue and exposure, patient and safety. Before the training they were asked to each think and pick a gene or protein of interest (it could be something they were working on, or read in a publication, etc) that they would focus for this course and perform evaluation as a drug target candidate according to the 5R principles.
At the end of the week they presented one slide summarizing the target they chose.